Thrivent Financial For Lutherans Krystal Biotech, Inc. Transaction History
Thrivent Financial For Lutherans
- $45.7 Billion
- Q2 2025
A detailed history of Thrivent Financial For Lutherans transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 18,700 shares of KRYS stock, worth $3.52 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,700
Previous 18,590
0.59%
Holding current value
$3.52 Million
Previous $3.35 Million
23.3%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding KRYS
# of Institutions
317Shares Held
24.7MCall Options Held
418KPut Options Held
485K-
Black Rock Inc. New York, NY3.95MShares$743 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$532 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.66MShares$501 Million6.67% of portfolio
-
State Street Corp Boston, MA1.36MShares$255 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA942KShares$177 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.83B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...